Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ingenasa is a Spanish biotechnology and diagnostics company focused on the development, manufacture, and commercialization of test kits and related products for animal health and food safety. Historically operating as Inmunología y Genética Aplicada, the company built a portfolio of ELISA, PCR, and lateral flow assays used to detect viral, bacterial, and food-related analytes, particularly in veterinary diagnostics. Its products are marketed under brands including INgezim, and the company has specialized in infectious diseases affecting farm and companion animals as well as selected food safety applications such as gluten detection. Ingenasa is now part of the Eurofins diagnostics network and operates under the Gold Standard Diagnostics Madrid identity within the broader Gold Standard Diagnostics brand. The business appears to be commercial-stage rather than a therapeutics developer, with revenue generated from diagnostic products and services rather than a clinical drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ingenasa.